Health-tech startup Fastest.Health, India’s first Quick Service Diagnostics (QSD) platform, has raised Rs 1.2 crore in pre-seed funding led by Inflection Point Ventures (IPV). The company plans to use the fresh capital to scale its marketing operations, enhance sales systems, strengthen its technology platform, and hire key talent to support its expansion.
Fastest.Health Funding
Currently operational in Navi Mumbai and suburban Mumbai, the startup aims to extend its reach to new cities as the demand for faster and reliable diagnostic services continues to grow. The company’s mission is to make healthcare diagnostics as swift and accessible as ordering food online, addressing an important gap in India’s healthcare ecosystem.
Founded by a team of experienced professionals from diverse sectors including diagnostics, logistics, e-commerce, and technology, Fastest.Health’s leadership team includes Jayesh Kamat (CEO), Sandeep Krishna (CBO), Mazhar Faruqi (COO), Dr. Santosh Wakchaure (CMO), and Mohit Lala (CTO). Together, they bring deep expertise in delivering technology-enabled healthcare services with precision and speed.
The company’s on-demand diagnostic model allows patients to book tests through its mobile app, after which samples are collected from their doorstep within 15 minutes. The startup’s system is designed to deliver most routine reports within 90 minutes, making it one of India’s fastest diagnostic responders.
Inflection Point Ventures Backing
Commenting on the investment, Vinay Bansal, Founder of Inflection Point Ventures, said that the COVID-19 pandemic has changed the healthcare landscape permanently, with speed, convenience, and accuracy becoming key priorities. He highlighted how technology now plays a critical role in making healthcare services more accessible. “Fastest.Health is demonstrating how rapid diagnostics can significantly cut treatment delays and improve patient outcomes,” he added.
According to Bansal, IPV’s decision to back Fastest.Health aligns with its philosophy of supporting tech-driven startups that solve real-world challenges. The funding is expected to accelerate the company’s ability to deliver fast, reliable, and affordable diagnostic services across urban and semi-urban markets.
Expanding with Technology
Sandeep Krishna, Co-founder and Chief Business Officer of Fastest.Health, expressed optimism about the partnership with IPV. He said the collaboration will strengthen their mission to redefine diagnostics in India by using advanced technology and operational excellence. “Our vision is to make diagnostics available faster than ever before, because when it comes to health, every minute matters,” he said.
Operational since January 2025, Fastest.Health has already conducted hundreds of diagnostic tests through NABL-accredited partner laboratories, ensuring certified quality and accuracy. The company has also developed a proprietary blood transport system, optimising both collection and processing times. Work is currently underway to launch 24×7 diagnostic services to ensure patients can access testing anytime, day or night.
India’s Diagnostic Boom
Industry analysts estimate that the Indian diagnostics market was valued at USD 14 billion in 2023, with projections suggesting growth to USD 20 billion by 2026. Fastest.Health is positioning itself to leverage this rapid expansion by offering speed, accessibility, and trusted results, which could set a new benchmark for diagnostics in the country.
The company’s mobile application, available on Android and iOS, provides users with a seamless interface for test bookings, live tracking, and digital report access. By focusing on turnaround time and convenience, Fastest.Health aims to become a preferred partner for both individual patients and healthcare providers seeking urgent, accurate results.
About Fastest.Health
Fastest.Health provides on-demand quick service diagnostics, ensuring doorstep sample collection within 15 minutes and test reports in 90 minutes through its mobile platform. All tests are conducted in NABL-accredited labs, guaranteeing accuracy and quality. The company’s mission is to redefine how India experiences medical testing — fast, simple, and reliable.
Inflection Point Ventures (IPV) is one of India’s largest angel investment networks, comprising over 24,000 CXOs, HNIs, and professionals. IPV provides startups with capital, mentorship, and strategic support to help them scale. The firm also manages Physis Capital, a $50 million Category II VC fund focused on growth-stage investments from pre-Series A to Series B. So far, the fund has invested in six companies, with more deals underway, reinforcing IPV’s role in shaping India’s startup ecosystem.
